Since 1997, the U.S. is one of only two countries (the other being New Zealand) that allows direct-to-consumer (DTC) advertising for health products like medications and procedures. Such DTC advertising in the U.S. increased from $2.1 billion in 1997 to $9.6 billion in 2016 — and continues to rise. And you wonder why two-thirds of […]
Source